ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1260

Lupus Diagnosis: Process and Patient Experience

Rossi Daly, Roushanac Partovi and Patricia Davidson, Lupus Foundation of America, Washington, DC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Communication, diagnosis and patient participation, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Delays in lupus diagnosis and misdiagnosis are sources of concern, as uncontrolled disease activity and early damage can increase mortality risk.1 The purpose of this study is to analyze the diagnostic process through the patient perspective and provide insight into unmet needs in lupus diagnosis.

Methods:

This cross-sectional study draws from a one-time online national survey conducted between December 2015 and January 2016 among 3,022 adults who self-reported a lupus diagnosis. To assess patient perspective on the diagnosis process, participants answered questions regarding symptoms pre-diagnosis, the provider(s) they discussed symptoms with, and the time frame to diagnosis. Descriptive statistics were conducted on demographic information and all diagnosis process measures.

Results:

Respondent characteristics are described in Table 1.

This analysis provides a detailed look at the diagnostic process from the patient perspective. Beginning with the symptoms prompting a first visit, musculoskeletal symptoms and fatigue illustrate the non-specificity experienced by nearly half of the respondents (Table 2). Of importance, a majority of respondents (73.2%) specifically made an appointment to discuss these symptoms, 72% discussing them with a primary care provider. Of those who discussed symptoms with other types of providers, over 75% also discussed the symptoms with a rheumatologist. Leading up to respondents’ diagnosis, more than half reported being told there was nothing wrong with them or that their symptoms were psychological (54.1%). Furthermore, 41% of respondents reported being told they had something other than lupus, and concurrently, nearly 40% of individuals waited more than one year from the onset of symptoms to receive an accurate diagnosis. At the time of diagnosis, over one third of respondents (34.5%) reported having severe symptoms.

Conclusion:

The findings of this study suggest the need to provide ongoing education to both primary care and specialty providers in diagnosing lupus. Qualitative responses in this study, not reported here, also suggest that poor provider-patient communications may contribute to the delay in diagnosis. Lastly, describing the providers and care settings typically involved in diagnosis can be useful for creating a framework to identify future areas of intervention and/or research.

1 Rahman P, Gladman D, Urowitz M, Hallett D. Early damage as measured by the SLICC/ACR damage index is a predictor or mortality in systemic lupus erythematosus. Lupus 2001; 10: 93-96.


Disclosure: R. Daly, None; R. Partovi, None; P. Davidson, None.

To cite this abstract in AMA style:

Daly R, Partovi R, Davidson P. Lupus Diagnosis: Process and Patient Experience [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/lupus-diagnosis-process-and-patient-experience/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-diagnosis-process-and-patient-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology